Furthermore, H2AX phosphorylation (γ-H2AX) was found to inhibit histone methylation via the binding to PRMT1 in cancer patients with overexpression of protein phosphatase 2A (PP2Ac), thereby increasing the level of histone phosphorylation (Thompson et al., 2013). Here, H2AX is linked to cancer.